Richard M Gale

Title: The Innovations of Richard M. Gale

Introduction

Richard M. Gale is a notable inventor based in Indianapolis, Indiana. He has made significant contributions to the field of antibiotics, particularly with his innovative work on glycopeptide antibiotics. With a total of three patents to his name, Gale's inventions have the potential to impact both human health and animal husbandry.

Latest Patents

One of Gale's latest patents is for the A80407 antibiotics, which are new glycopeptide antibiotics comprising A80407A and A80407B. These antibiotics are produced by Kibdelosporangium philippinensis strains NRRL 18198 and NRRL 18199, or A80407-producing mutants of these strains. The A80407 antibiotics exhibit excellent activity against Gram-positive bacteria, enhance feed-utilization efficiency in monogastric and ruminant animals, and improve weight gains in these animals.

Career Highlights

Richard M. Gale is currently associated with Eli Lilly and Company, a leading pharmaceutical company known for its innovative research and development in healthcare. His work at Eli Lilly has allowed him to focus on developing new antibiotics that can address pressing health challenges.

Collaborations

Gale has collaborated with notable coworkers such as Lawrence E. Doolin and Otis W. Godfrey. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Richard M. Gale's contributions to antibiotic innovation, particularly through his A80407 patents, highlight his role as a significant inventor in the pharmaceutical industry. His work not only addresses critical health issues but also enhances agricultural practices.